EMA seeks to work with government payers

Monday 1 March 2010

The European Medicines Agency (EMA) is looking at ways it can work more closely with government bodies in Europe whose responsibility it is to decide whether or not to subsidize a new medicine based on its relative effectiveness.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United Kingdom

See map: Google Maps